Adverse Outcome Pathway Development II: Best Practices

Organization of existing and emerging toxicological knowledge into adverse outcome pathway (AOP) descriptions can facilitate greater application of mechanistic data, including those derived through high-throughput in vitro, high content omics and imaging, and biomarker approaches, in risk-based deci...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Toxicol Sci
Asıl Yazarlar: Villeneuve, Daniel L., Crump, Doug, Garcia-Reyero, Natàlia, Hecker, Markus, Hutchinson, Thomas H., LaLone, Carlie A., Landesmann, Brigitte, Lettieri, Teresa, Munn, Sharon, Nepelska, Malgorzata, Ottinger, Mary Ann, Vergauwen, Lucia, Whelan, Maurice
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2014
Konular:
Forum: Use of Adverse Outcome Pathways in Toxicology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4318924/
https://ncbi.nlm.nih.gov/pubmed/25466379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/toxsci/kfu200
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller